1. 420PPhase I/II study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours. (23rd October 2018) Authors: Bono, P; Massard, C; Peltola, K; Azaro, A; Italiano, A; Kristeleit, R S; Lassen, U N; Arkenau, H-T; Hakulinen, P; Garratt, C; Ikonen, T; Mustonen, M; Rodon, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 835PCYP11A1 inhibition as a therapeutic approach for the treatment of castration resistant prostate cancer. (23rd October 2018) Authors: Oksala, R; Räsänen, K; Karimaa, M; Riikonen, R; Ramela, M; Vehmaan-Kreula, P; Simola, O; Rummakko, P; Wohlfahrt, G; Mustonen, M Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗